SCHEMBL16247703

SCHEMBL16247703

Cc1cccc(-c2cccc(C(=O)O)c2C)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKR1C2 P52895 2/20 0.51
▸ AKR1C1 Q04828 1/20 0.51
▸ POLB P06746 3/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ CNR2 P34972 1/20 0.48
▸ SYK P43405 2/20 0.47
▸ HNF4A P41235 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ MYC P01106 1/20 0.46
▸ KMO O15229 2/20 0.45
▸ DHODH Q02127 1/20 0.45
▸ MCL1 Q07820 2/20 0.45
▸ BAD Q92934 1/20 0.45
▸ PTGER1 P34995 1/20 0.44
▸ AKR1C3 P42330 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268963 0.88 L3MBTL1 (0.59) AKR1C2AKR1C1POLBL3MBTL1CNR2
SCHEMBL30361685 0.88 L3MBTL1 (0.59) AKR1C2AKR1C1POLBL3MBTL1CNR2
SCHEMBL121422 0.85 HNF4A (0.63) AKR1C2AKR1C1POLBL3MBTL1HNF4A
SCHEMBL13504679 0.85 HNF4A (0.50) AKR1C2AKR1C1POLBL3MBTL1SYK
SCHEMBL6849570 0.85 HNF4A (0.69) AKR1C2AKR1C1POLBL3MBTL1CNR2
SCHEMBL23908687 0.82 AKR1C2 (0.48) AKR1C2AKR1C1POLBL3MBTL1CNR2
SCHEMBL2556585 0.82 NR1H4 (0.46) AKR1C2AKR1C1POLBL3MBTL1SYK
SCHEMBL5046158 0.81 MYC (0.59) AKR1C2AKR1C1POLBL3MBTL1HNF4A
SCHEMBL2559209 0.81 TRIM24 (0.53) POLBL3MBTL1SYKHNF4AALDH1A1
SCHEMBL15515383 0.81 DHODH (0.51) AKR1C2AKR1C1POLBL3MBTL1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238637-B2 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof BEIJING BETTA PHARMACEUTICALS CO., LTD (CN) 2016-01-19 — — US disclosed
US-20140343137-A1 Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343137-A1 Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof HIF1A, HIF1AN, COXFA4L2 AKR1C2 497/4885AKR1C1 594/4885POLB 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback